How Genes Affect Lung Disease Development
Part of Blood & lymphatic, Brain & nervous system, Cancer, Digestive system, Genetic & congenital, Immune system & allergy, Lungs & breathing clinical trials.
This research study examines how genetic factors contribute to various lung diseases, including alpha-1 antitrypsin deficiency, cystic fibrosis, and chronic obstructive pulmonary disease. Researchers want to understand why some people develop lung disease and how genetics plays a role, which may help improve treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed lung condition (such as AAT deficiency, cystic fibrosis, COPD, sarcoidosis, or another condition listed) or you are a healthy volunteer or relative of someone with a lung disease
- You have evidence of lung disease on chest X-ray and/or abnormal lung function tests (or you are a healthy control participant)
- You are at least 18 years old (some conditions like cystic fibrosis allow ages 8+, and some genetic conditions allow ages 2+)
- You are able to complete lung function breathing tests reliably
- You do not have a serious condition that would make study procedures too risky
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genes are linked to different types and severities of asthma. It aims to understand why asthma affects people differently, which could lead to better treatments.
This study looks at genetic differences in people with idiopathic pulmonary fibrosis (a lung scarring condition with no known cause). It may help researchers understand what influences the disease and guide future treatment options.
This study looks at how lung disease changes a type of blood cell called white blood cells. It may help researchers understand what’s happening in the lungs and how to better monitor or treat lung problems.
This study screens for a rare genetic condition called Alpha-1 Antitrypsin Deficiency in people with lung blockage. It aims to find out if this deficiency is a hidden cause of your breathing problems, which could lead to better treatment options.
This study follows adults with a genetic condition called alpha-1 antitrypsin deficiency (a rare protein deficiency) who have liver disease. Researchers will examine stored blood and tissue samples to understand why some people's livers are damaged more than others, which may help develop better treatments.
This study looks at how genetic differences in alpha-1 antitrypsin deficiency affect immune response to a pneumonia vaccine. It may help find better ways to prevent lung infections.
Hear when a new Cystic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.